Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Interim Management Statement Notification

14th Jul 2009 15:45

RNS Number : 6530V
United Drug PLC
14 July 2009
 



Interim Management Statement Notification

United Drug plc, a leading international provider of services to healthcare

manufacturers and pharmaceutical retailers, will issue an Interim Management Statement at 07.00 BST on Friday, 31 July 2009.

Ends Tuesday, 14 July 2009.

Contact:

Karen Geoghegan

Tel: +353-1-4637720

About United Drug plc

United Drug is a leading international provider of services to healthcare manufacturers and pharmaceutical retailers, with operations in the UK, Ireland, Holland, Belgium and the USA. The Company has a long-term track record of delivering strong profit, earnings and dividend growth. 

At the end of the 2008 financial year the Company announced the streamlining of its divisional structure into three new divisions (see overleaf). This allows for a better alignment of the businesses with the management and operating structure in the Group, improved communications throughout the Group and the delivery of synergies. The restructuring brings together all parts of the business involved in the delivery of healthcare products under one management and operating structure within a newly formed Healthcare Supply Chain division. The Group's packaging operations and speciality services will form a new Packaging & Speciality division and the contract sales business will continue to be reported as the Contract Sales & Marketing Services division.

In Healthcare Supply Chain, United Drug is the largest pharmaceutical wholesaler in the island of Ireland. It is also the market leader in contract distribution outsourcing (pre-wholesaling) in Ireland and has achieved the No. 1 position in the UK through its joint venture business UniDrug Distribution Group (UDG). The Company provides specials medicines manufacturing and distribution services in the UK. The Company also provides sales & marketing and technical service solutions, including contract distribution services to Medical & Scientific equipment & consumable manufacturers, with a market leading position in Ireland and an emerging presence in the UK.

In the Packaging & Speciality division United Drug is a leading international provider of pharmaceutical contract packaging services with facilities in the US, UK, Dutch and Belgian markets. The Company also provides speciality distribution services in the UK and Irish markets.

In the Contract Sales & Marketing Services division United Drug is a leading provider of contract sales outsourcing and related marketing services to pharmaceutical manufacturers in the UK, US and Ireland.

This announcement has been issued through the Companies Announcement Service of

the Irish Stock Exchange.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEBSGDRUSBGGCS

Related Shares:

UDG.L
FTSE 100 Latest
Value8,275.66
Change0.00